Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2010
10/06/2010EP2236511A2 Ligands of alpha-adrenoceptors and of dopamine, histamine, imidazoline and serotonin receptors and the use thereof
10/06/2010EP2236503A1 Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
10/06/2010EP2236161A1 Polymer conjugates of opioid antagonists
10/06/2010EP2236158A1 New therapeutic approaches for treating neuroinflammatory conditions
10/06/2010EP2236156A2 Methods for treating and diagnosing Psoriasis
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2236142A1 Medical use of conjugated polyelectrolytes
10/06/2010EP2236138A1 Low dose pipamperone in treating mood and anxiety disorders
10/06/2010EP2236133A1 Pharmaceutical composition comprising fentanyl for the treatment of acute or breakthrough pain by sublingual administration
10/06/2010EP2236132A1 Pharmaceutical composition for the treatment of insomnia by sublingual administration
10/06/2010EP2236131A2 Compositions for manipulating the lifespan and stress response of cells and organisms
10/06/2010EP2235175A1 Polypeptide-nucleic acid conjugates and uses thereof
10/06/2010EP2235058A2 Anti-amyloid antibodies and uses thereof
10/06/2010EP2235013A1 Substituted tetrahydroimidazopyridine compounds and the use thereof in pharmaceuticals
10/06/2010EP2235009A1 Synthesis of paliperidone
10/06/2010EP2235006A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
10/06/2010EP2235003A1 Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
10/06/2010EP2234999A1 Heteroaryl derivatives as orexin receptor antagonists
10/06/2010EP2234990A1 Bifeprunox derivatives
10/06/2010EP2234981A1 Novel imidazole-substituted arylamides
10/06/2010EP2234976A1 Novel pyrazole-substituted arylamides
10/06/2010EP2234972A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
10/06/2010EP2234954A1 Tetrasubstituted benzenes
10/06/2010EP2234633A1 A method of treating neurodegenerative diseases
10/06/2010EP2234617A1 Dosing regimen associated with long acting injectable paliperidone esters
10/06/2010EP2234616A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/06/2010EP1910325B1 New pharmaceutical compounds
10/06/2010EP1776349B1 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (bace)
10/06/2010EP1751093B1 Substituted cyclohexylacetic acid derivatives
10/06/2010EP1745295B1 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
10/06/2010EP1723144B1 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/06/2010EP1633752B1 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
10/06/2010EP1513543B1 Fas peptide mimetics and uses thereof
10/06/2010EP1352077B1 Materials and methods relating to protein aggregation in neurodegenerative disease
10/06/2010EP1296951B1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3'] bipyridinyl in pure crystalline form and process for synthesis
10/06/2010EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
10/06/2010CN1914212B Polymorphic forms of a GABAA agonist
10/06/2010CN1681508B Novel inhibitors of kinases
10/06/2010CN1665501B Novel compounds as opioid receptor modulators
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN101855229A Spirocyclic aminoquinolones as GSK-3 inhibitors
10/06/2010CN101855228A Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors
10/06/2010CN101855227A Heterocyclic derivatives
10/06/2010CN101855222A Imidazol (1,2-A)pyridines and related compounds with activity at cannabinoid CB2 receptors
10/06/2010CN101855213A Therapeutic compounds
10/06/2010CN101855209A Alkylsulfone derivative
10/06/2010CN101855208A 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof
10/06/2010CN101855200A New polymorphic forms of N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide
10/06/2010CN101854935A Metabotropic glutamate receptor modulators for the treatment op parkinson's disease
10/06/2010CN101851300A Process for extracting chondroitin sulfate
10/06/2010CN101851236A Preparations of new polymorphic forms of varenicline tartrate
10/06/2010CN101851234A Pyrrolequinoline quinone lithium salt derivative and preparation method thereof
10/06/2010CN101851220A Isoprene flavonoid compound and application thereof
10/06/2010CN101851201A Preparation method of setiptiline and maleate thereof
10/06/2010CN101851184A Acamprosate agmatine salt and analogue thereof
10/06/2010CN101851170A Chlocibutamine type II crystals
10/06/2010CN101851165A Glutamate of O-demethyl-venlafaxine and preparation method thereof
10/06/2010CN101850123A Inorganic nano hybrid material of nuclear-shell-type fluorescent-labeled magnetic medicine and preparation method thereof
10/06/2010CN101850120A Solutions and methods for inhibition of pain, inflammation and cartilage degradation
10/06/2010CN101850119A Compound preparation used for treating melancholia and senile dementia
10/06/2010CN101850109A Smoke-resisting cancer prevention compound
10/06/2010CN101850097A Chinese medicinal composition for treating medial headache and migraine and preparation method thereof
10/06/2010CN101850096A External Chinese medicinal composition for treating hydrocephalus and preparation method thereof
10/06/2010CN101850090A Chinese medicinal preparation for treating insomnia depression
10/06/2010CN101850087A Medicinal composition used for alleviating pains and preparation method and application thereof
10/06/2010CN101850069A Oral Chinese patent medicament capsule for treating white hair of teenagers
10/06/2010CN101850058A Chinese medicament for preventing and treating agrypnia, memory loss and alzheimers disease and method
10/06/2010CN101850053A Pharmaceutical composition containing Japanese stephania root
10/06/2010CN101850001A Pharmaceutical composition with function of improving sleep and preparation method thereof
10/06/2010CN101849990A Pharmaceutical composition with function of improving memory and preparation method thereof
10/06/2010CN101849968A Kidney-tonifying capsule medicament and preparation method thereof
10/06/2010CN101849931A Medicament for treating encephalatrophy or encephalatrophic dementia
10/06/2010CN101849926A Zolpidem tartrate film
10/06/2010CN101849925A Rizatriptan benzoate film agent
10/06/2010CN101849924A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
10/06/2010CN101849921A Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
10/06/2010CN101849919A N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same
10/06/2010CN101849903A Suppository for alleviating pain
10/06/2010CN101601828B Eyesight-recovering traditional Chinese medicine for treating optic neuritis and optic nerve atrophy
10/06/2010CN101301447B Chinese medicinal composition for treating epilepsy
10/06/2010CN101301089B Medicinal meat balls for curing insomnia
10/06/2010CN101220359B SiRNA sequence restraining bak gene expression
10/06/2010CN101199609B Chinese medicine for treating chemo-treatment medicament derived peripheral nerve toxicity
10/06/2010CN101168009B Quality control method of macaque stone bovinebezoar powder
10/06/2010CN101156835B Preparation method of hypericin oral liquid
10/06/2010CN101152205B Inosine injection and method of preparing the same
10/06/2010CN101152178B Sophoridine nano liposome medicament and preparation of the same
10/06/2010CN101058823B Method of preparing cytidine disodium triphosphate and application
10/06/2010CN101041052B Chinese traditional medicine compound took orally for treating Raynand's disease
10/06/2010CN100998707B Medical herbs of decoction for treating sciatica and its preparing method
10/05/2010US7807700 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/05/2010US7807689 such as 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile, used for the treatment of breast cancer and non-insulin depepndent diabetes
10/05/2010US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders
10/05/2010US7807667 4-(5-Benzo[1,3]dioxol-5-yl-[1,3,4]oxadiazol-2-yl)-1,4-diaza-bicyclo[3.2.2]-nonane or fumaric acid salt; diseases or disorders related to smooth muscle contraction, endocrine diseases, neurodegenerative disorders, inflammation, pain, and withdrawal symptoms caused by the termination of substance abuse
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010US7807658 Administering an optionally substituted 3-aminopropylphosphinic acid (3-amino-2-fluoropropyl)phosphinic acid, 3-amino-2-oxopropyl)phosphinic acid); irritable bowel syndrome
10/05/2010US7807655 uridine-5'-monophosphate or cytidine-5'-monophosphate for the treatment of affections of the peripheral nervous system, particularly polyneuropathies, neuritides, and myopathies; for stimulating the regeneration of nerves
10/05/2010US7807654 Compositions and methods for treatment of mitochondrial diseases
10/05/2010US7807430 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening
10/05/2010US7807390 G-protein coupled receptor ligands and methods
1 ... 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 ... 1833